In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Valentis enters cross license agreement with Genzyme
Juvaris BioTherpeutics Expands Relationship With Valentis
Valentis initiates gene therapy clinical trial
Valentis licenses delivery technology to Juvaris
Eurogene and Valentis initiate trial for prevention of blood vessel hyperplasia
Eurogene and Valentis announce collaboration
Valentis Expands License Agreement With Genzyme Corporation
Valentis introduces new gene delivery systems for secreted proteins